NEW YORK (360Dx) – A protein shed into the cerebrospinal fluid acts as a marker of inflammation during early Alzheimer's disease development, researchers from Germany and the US have found.

Alzheimer's disease is thought to be driven by the accumulation of amyloid-beta, which then leads to a cascade of events, including the development of plaques, to bring on cognitive decline. At the same time, inflammatory events and the activation of microglia are suspected to have a role in disease development, though how they fit into that progression has been unclear.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.